Bicara Therapeutics BCAX
NASDAQ BCAX
$17.61 -0.30 (-1.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Bicara Therapeutics (BCAX) Other non-cash items (2024 - 2026)

Updated

Analysis

Bicara Therapeutics (BCAX) Other non-cash items (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Bicara Therapeutics 1.16 Bn -580.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 277,000.00
Mar 31, 2026 273,000.00
Sep 30, 2025 249,000.00
Jun 30, 2025 211,000.00
Mar 31, 2025 138,000.00
Sep 30, 2024 68,000.00
Jun 30, 2024 66,000.00
Mar 31, 2024 65,000.00
API Access

Bicara Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=BCAX&period=max&api_key=YOUR_API_KEY